mirjammoerbeek Goto Github PK

bayesiansequentialdesigns

bayesianupdating

Moerbeek, M. (2021). Bayesian updating: increasing sample size during the course of a study. BMC Medical Research Methodology, 21: 137.

covariate_imbalance_crt

Moerbeek, M. & Van Schie, S. (2016). How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level. BMC Medical Research Methodology, 16: 79.

crt_missing_data

Moerbeek, M. (2021). The effect of missing data on design efficiency in repeated cross-sectional multi-period parallel-arm cluster randomized trials. Behavior Research Methods, 53: 1731-1745.

crt_outcomes_both_levels

Moerbeek, M. (2020). Optimal designs for group randomized trials and group administered treatments with outcomes at the subject and group level. Statistical Methods in Medical Research, 29(3): 797-810.

crxo_attrition_abba

Moerbeek, M. (2020). The cluster randomized crossover trial: the effects of attrition in the AB/BA design and how to account for it in sample size calculations. Clinical Trials, 17(4): 420-429

od_crxo

Optimal design of cluster randomized crossover trials with time periods of fixed duration

od_ordinal

Moerbeek, M. (2021). Optimal allocations for two treatment comparisons within the proportional odds cumulative logits model. PLOS ONE, 16(4): e0250119.

optimal_crswd

optimal_irswd

Moerbeek, M. (accepted). Optimal allocation to treatment sequences in individually randomized stepped wedge designs with attrition. Clinical Trials.

optimal_placebo_treatment_comparisons

power_piecewise_growth

Moerbeek, M. (accepted). Power analysis of longitudinal studies with piecewise linear growth and attrition. Behavioral Research Methods

spa_ml

Moerbeek, M., Teerenstra, S. (2016). Power analysis of trials with multilevel data. Boca Raton: CRC Press.

three_arm_trials

Moerbeek, M. (2018). Cost-efficient designs for three-arm trials with treatment delivered by health professionals: sample sizes for a combination of nested and crossed designs. Clinical trials, 15(2): 169-177.